Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/B ratio high or low?
The P/B ratio of 1.71 is 48% above its estimated 5-year average of 1.16, around the middle of its estimated 5-year range (0.22–4.27).
As of 2026-10-06T21:41:58.661Z. 14.13% below its estimated 12-month average of 1.99.
Calculation as of: 2026-10-06T21:41:58.661Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a840c676881d241076febf00b391d6b63dc7604cd07ac1d060a0848db02ea459
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
1.71
PB RATIO AVG TTM
1.99
PB RATIO AVG 3Y
1.54
PB RATIO AVG 5Y
1.16
PB RATIO AVG 10Y
N/A
PB RATIO AVG 15Y
N/A
PB RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-14.13%
CURRENT VS 3Y AVG
+11.32%
CURRENT VS 5Y AVG
+47.63%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.39
median of 761 covered companies
CURRENT VS SECTOR MEDIAN
-28.45%
vs the sector median at left
Inhibikase Therapeutics, Inc.
Market Cap
$261.43M
PB Ratio
1.71
TTM Avg
1.99
3Y Avg
1.54
5Y Avg
1.16
Market Cap
$262.92M
PB Ratio
40.14
TTM Avg
27.53
3Y Avg
23.23
5Y Avg
12.13
Market Cap
$259.49M
PB Ratio
3.83
TTM Avg
2.68
3Y Avg
3.74
5Y Avg
7.65
Market Cap
$259.14M
PB Ratio
2.55
TTM Avg
4.86
3Y Avg
12.57
5Y Avg
12.57
Market Cap
$259.12M
PB Ratio
1.10
TTM Avg
2.71
3Y Avg
2.16
5Y Avg
2.16
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | $261.43M | 1.71 | 1.99 | 1.54 | 1.16 |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.27M | 1.68 | 3.11 | 16.45 | 10.63 |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | 40.14 | 27.53 | 23.23 | 12.13 |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | 0.82 | 0.69 | 0.78 | 0.94 |
| Treace Medical Concepts, Inc. (TMCI)vs › | $259.49M | 3.83 | 2.68 | 3.74 | 7.65 |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.14M | 2.55 | 4.86 | 12.57 | 12.57 |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $259.12M | 1.10 | 2.71 | 2.16 | 2.16 |
| Palisade Bio, Inc. (PALI)vs › | $258.63M | 2.12 | 3.32 | 2.33 | 8.64 |
| Scribe Therapeutics Inc. (SCTX)vs › | $264.25M | N/A | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $265.78M | 1.60 | 4.41 | 4.27 | 3.70 |
At 1.71, P/B is above its estimated 6-year median — higher than 65% of readings in its estimated 6-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 6-year low
0.22
median
0.89
estimated 6-year high
7.71
P/B Ratio
1.71
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PB RATIO |
|---|---|
| 2026-10-05 | 2.28 |
| 2026-10-02 | 2.28 |
| 2026-10-01 | 2.20 |
| 2026-09-30 | 2.35 |
| 2026-09-29 | 2.30 |
| 2026-09-28 | 2.33 |
| 2026-09-25 | 2.35 |
| 2026-09-24 | 2.39 |
| 2026-09-23 | 2.45 |
| 2026-09-22 | 2.63 |
| 2026-09-21 | 2.50 |
| 2026-09-18 | 2.62 |
| 2026-09-17 | 2.62 |
| 2026-09-16 | 2.63 |
| 2026-09-15 | 2.63 |
| 2026-09-14 | 2.72 |
| 2026-09-11 | 2.66 |
| 2026-09-10 | 2.65 |
| 2026-09-09 | 2.74 |
| 2026-09-08 | 2.77 |
| 2026-09-04 | 2.85 |
| 2026-09-03 | 2.87 |
| 2026-09-02 | 2.85 |
| 2026-09-01 | 2.71 |
| 2026-08-31 | 2.63 |
| 2026-08-28 | 2.74 |
| 2026-08-27 | 2.81 |
| 2026-08-26 | 2.83 |
| 2026-08-25 | 2.85 |
| 2026-08-24 | 2.85 |
| 2026-08-21 | 2.72 |
| 2026-08-20 | 2.68 |
| 2026-08-19 | 2.79 |
| 2026-08-18 | 2.73 |
| 2026-08-17 | 2.72 |
| 2026-08-14 | 2.74 |
| 2026-08-13 | 2.74 |
| 2026-08-12 | 2.73 |
| 2026-08-11 | 2.52 |
| 2026-08-10 | 2.53 |
| 2026-08-07 | 2.54 |
| 2026-08-06 | 2.48 |
| 2026-08-05 | 2.47 |
| 2026-08-04 | 2.51 |
| 2026-08-03 | 2.27 |
| 2026-07-31 | 2.24 |
| 2026-07-30 | 2.34 |
| 2026-07-29 | 2.27 |
| 2026-07-28 | 2.37 |
| 2026-07-27 | 2.42 |
| 2026-07-24 | 2.40 |
| 2026-07-23 | 2.40 |
| 2026-07-22 | 2.23 |
| 2026-07-21 | 2.29 |
| 2026-07-20 | 2.29 |
| 2026-07-17 | 2.17 |
| 2026-07-16 | 2.07 |
| 2026-07-15 | 2.12 |
| 2026-07-14 | 2.12 |
| 2026-07-13 | 2.01 |
| 2026-07-10 | 2.10 |
| 2026-07-09 | 2.10 |
| 2026-07-08 | 2.13 |
| 2026-07-07 | 2.11 |
| 2026-07-06 | 2.04 |
| 2026-07-02 | 2.05 |
| 2026-07-01 | 1.99 |
| 2026-06-30 | 2.09 |
| 2026-06-29 | 1.98 |
| 2026-06-26 | 1.96 |
| 2026-06-25 | 1.92 |
| 2026-06-24 | 1.92 |
| 2026-06-23 | 1.92 |
| 2026-06-22 | 1.89 |
| 2026-06-18 | 1.88 |
| 2026-06-17 | 1.73 |
| 2026-06-16 | 1.72 |
| 2026-06-15 | 1.72 |
| 2026-06-12 | 1.72 |
| 2026-06-11 | 1.72 |
| 2026-06-10 | 1.71 |
| 2026-06-09 | 1.72 |
| 2026-06-08 | 1.67 |
| 2026-06-05 | 1.68 |
| 2026-06-04 | 1.71 |
| 2026-06-03 | 1.72 |
| 2026-06-02 | 1.75 |
| 2026-06-01 | 1.76 |
| 2026-05-29 | 1.80 |
| 2026-05-28 | 1.82 |
| 2026-05-27 | 1.75 |
| 2026-05-26 | 1.75 |
| 2026-05-22 | 1.74 |
| 2026-05-21 | 1.79 |
| 2026-05-20 | 1.73 |
| 2026-05-19 | 1.61 |
| 2026-05-18 | 1.66 |
| 2026-05-15 | 1.78 |
| 2026-05-14 | 1.91 |
| 2026-05-13 | 1.95 |
| 2026-05-12 | 1.05 |
| 2026-05-11 | 1.11 |
| 2026-05-08 | 1.12 |
| 2026-05-07 | 1.08 |
| 2026-05-06 | 1.09 |
| 2026-05-05 | 1.05 |
| 2026-05-04 | 1.06 |
| 2026-05-01 | 1.04 |
| 2026-04-30 | 1.03 |
| 2026-04-29 | 1.01 |
| 2026-04-28 | 1.02 |
| 2026-04-27 | 1.03 |
| 2026-04-24 | 1.02 |
| 2026-04-23 | 1.05 |
| 2026-04-22 | 0.99 |
| 2026-04-21 | 0.91 |
| 2026-04-20 | 0.99 |
| 2026-04-17 | 1.00 |
| 2026-04-16 | 0.93 |
| 2026-04-15 | 0.98 |
| 2026-04-14 | 0.93 |
| 2026-04-13 | 0.93 |
| 2026-04-10 | 0.93 |
| 2026-04-09 | 0.92 |
| 2026-04-08 | 0.95 |
| 2026-04-07 | 0.96 |
| 2026-04-06 | 0.98 |
| 2026-04-02 | 0.98 |
| 2026-04-01 | 0.99 |
| 2026-03-31 | 0.92 |
| 2026-03-30 | 0.86 |
| 2026-03-27 | 0.92 |
| 2026-03-26 | 2.01 |
| 2026-03-25 | 2.01 |
| 2026-03-24 | 1.98 |
| 2026-03-23 | 2.15 |
| 2026-03-20 | 2.22 |
| 2026-03-19 | 2.26 |
| 2026-03-18 | 2.26 |
| 2026-03-17 | 2.42 |
| 2026-03-16 | 2.45 |
| 2026-03-13 | 2.47 |
| 2026-03-12 | 2.46 |
| 2026-03-11 | 2.50 |
| 2026-03-10 | 2.41 |
| 2026-03-09 | 2.33 |
| 2026-03-06 | 2.32 |
| 2026-03-05 | 2.33 |
| 2026-03-04 | 2.41 |
| 2026-03-03 | 2.36 |
| 2026-03-02 | 2.38 |
| 2026-02-27 | 2.53 |
| 2026-02-26 | 2.58 |
| 2026-02-25 | 2.64 |
| 2026-02-24 | 2.53 |
| 2026-02-23 | 2.22 |
| 2026-02-20 | 2.17 |
| 2026-02-19 | 2.15 |
| 2026-02-18 | 2.22 |
| 2026-02-17 | 2.09 |
| 2026-02-13 | 2.06 |
| 2026-02-12 | 2.03 |
| 2026-02-11 | 2.11 |
| 2026-02-10 | 1.98 |
| 2026-02-09 | 2.04 |
| 2026-02-06 | 2.10 |
| 2026-02-05 | 1.95 |
| 2026-02-04 | 1.93 |
| 2026-02-03 | 1.95 |
| 2026-02-02 | 1.94 |
| 2026-01-30 | 1.85 |
| 2026-01-29 | 1.94 |
| 2026-01-28 | 1.96 |
| 2026-01-27 | 2.09 |
| 2026-01-26 | 2.04 |
| 2026-01-23 | 2.15 |
| 2026-01-22 | 2.22 |
| 2026-01-21 | 2.16 |
| 2026-01-20 | 2.04 |
| 2026-01-16 | 2.06 |
| 2026-01-15 | 2.04 |
| 2026-01-14 | 2.10 |
| 2026-01-13 | 2.08 |
| 2026-01-12 | 2.11 |
| 2026-01-09 | 2.12 |
| 2026-01-08 | 2.06 |
| 2026-01-07 | 2.33 |
| 2026-01-06 | 2.47 |
| 2026-01-05 | 2.48 |
| 2026-01-02 | 2.41 |
| 2025-12-31 | 2.53 |
| 2025-12-30 | 2.43 |
| 2025-12-29 | 2.42 |
| 2025-12-26 | 2.47 |
| 2025-12-24 | 2.04 |
| 2025-12-23 | 1.96 |
| 2025-12-22 | 2.05 |
| 2025-12-19 | 2.12 |
| 2025-12-18 | 2.06 |
| 2025-12-17 | 1.96 |
| 2025-12-16 | 1.98 |
| 2025-12-15 | 2.00 |
| 2025-12-12 | 1.90 |
| 2025-12-11 | 1.89 |
| 2025-12-10 | 1.83 |
| 2025-12-09 | 1.80 |
| 2025-12-08 | 1.78 |
| 2025-12-05 | 1.85 |
| 2025-12-04 | 1.87 |
| 2025-12-03 | 1.78 |
| 2025-12-02 | 1.74 |
| 2025-12-01 | 1.85 |
| 2025-11-28 | 1.88 |
| 2025-11-26 | 1.90 |
| 2025-11-25 | 1.94 |
| 2025-11-24 | 1.91 |
| 2025-11-21 | 1.84 |
| 2025-11-20 | 1.89 |
| 2025-11-19 | 1.93 |
| 2025-11-18 | 1.98 |
| 2025-11-17 | 1.88 |
| 2025-11-14 | 1.72 |
| 2025-11-13 | 1.80 |
| 2025-11-12 | 1.82 |
| 2025-11-11 | 1.84 |
| 2025-11-10 | 1.79 |
| 2025-11-07 | 1.69 |
| 2025-11-06 | 1.68 |
| 2025-11-05 | 1.91 |
| 2025-11-04 | 1.79 |
| 2025-11-03 | 1.80 |
| 2025-10-31 | 1.65 |
| 2025-10-30 | 1.64 |
| 2025-10-29 | 1.61 |
| 2025-10-28 | 1.65 |
| 2025-10-27 | 1.75 |
| 2025-10-24 | 1.73 |
| 2025-10-23 | 1.72 |
| 2025-10-22 | 1.73 |
| 2025-10-21 | 1.78 |
| 2025-10-20 | 1.82 |
| 2025-10-17 | 1.77 |
| 2025-10-16 | 1.70 |
| 2025-10-15 | 1.80 |
| 2025-10-14 | 1.82 |
| 2025-10-13 | 1.83 |
| 2025-10-10 | 1.81 |
| 2025-10-09 | 1.87 |
| 2025-10-08 | 1.87 |
| 2025-10-07 | 1.82 |
| 2025-10-06 | 1.82 |
| 2025-10-03 | 1.87 |
| 2025-10-02 | 1.84 |
| 2025-10-01 | 1.81 |
| 2025-09-30 | 1.82 |
| 2025-09-29 | 1.72 |
| 2025-09-26 | 1.74 |
| 2025-09-25 | 1.74 |
| 2025-09-24 | 1.93 |
| 2025-09-23 | 1.82 |
Showing the most recent 260 of 1,295 data points. The chart above shows the full history.